Skip to main content

Table 1 Number of rats by lung histopathological findings between treatments

From: Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage

Variable

Severity

Cicl/Dex

Ator

Vit C

HepSC

HepIT

PQ

p

n = 9

n = 9

n = 9

n = 9

n = 9

n = 9

Alveolar injury

Absent/mild

4

3

1

2

2

1

0.5275

Moderate/severe

5

6

8

7

7

8

Lung inflammation

Absent/mild

1

4

0

1

4

0

0.2699

Moderate/severe

8

5

9

8

5

9

Interstitial fibrosis

Absent/mild

7

9

9

7

8

9

0.2699

Moderate/severe

2

0

0

2

1

0

  1. Cicl/Dex cyclophosphamide–dexamethasone, Ator atorvastatin, Vit C vitamin C, HepSC low molecular weight heparin, HepIT unfractionated heparin intratracheal, PQ paraquat